SLCG Economic Consulting's Logo

Morgan Stanley Issued $12,069,110 Contingent Income Auto-Callable Securities
April, 2025

$12,069,110 Contingent Income Auto-Callable Securities Based on the Performance of the Common Stock of Moderna, Inc. due October 18, 2024, priced on October 15, 2021, were issued by Morgan Stanley Finance LLC. The pricing supplement for this note (CUSIP: 61773G150) can be found here.

The notes had a $10 face value and paid a quarterly coupon of $0.2575, so long as the notes had not been called and and Moderna all closed above 55% of their October 15, 2021 closing prices on a determination date. If and Moderna closed below 55% of their October 15, 2021 closing prices on a determination date, the notes did not pay a coupon.

If not previously called, at maturity, the notes returned $10 in principal if and Moderna all closed on the final determination date on October 15, 2024 and above 55% of their October 15, 2021 closing prices. If on October 15, 2024 and Moderna closed below 55% of their October 15, 2021 closing prices, the notes paid reduced principal euqal to $10 multiplied by the lowest ratio of and Moderna October 15, 2024 closing prices to their October 15, 2021 closing prices.

The notes have matured. They paid four coupons totaling $0.5150 and $1.77 repayment per $10 note. Investors thus suffered capital losses of $8.23 and net losses of $7.72. In the aggregate, investors in this note suffered $9,935,676 in capital losses and $9,314,117 in net losses. See Table 1 and Figure 1.

Table 1



Figure 1




SLCG estimated these losses based on publicly available information. The issuer ultimately determines the amounts paid which may differ from our estimates. Our reference to capital loss and net loss does not imply SLCG's view of how these losses are treated for tax purposes.


If you have questions about this post, please contact SLCG for an initial consultation or email us at info@SLCG.com.

SLCG Economic Consulting, LLC

SLCG Economic Consulting, LLC ("SLCG") specializes in finance, economics, and investment management consulting services. We offer expert witness services tailored to meet the needs of law firms, banks, brokerage firms, and individuals navigating complex litigation. Our team predominantly comprises PhD and MA-level professionals with varied backgrounds spanning academia, industry, and government. Numerous team members have offered expert testimony in state and federal courts, as well as in diverse arbitration forums.

SLCG is a wholly owned subsidiary of McCann Yan Holdings, Inc., a Virginia incorporated company based in Northern Virginia.